XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover Page - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2021
Mar. 25, 2022
Jun. 30, 2021
Document Information [Line Items]      
Entity Registrant Name Celularity Inc.    
Document Type 10-K/A    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   137,720,526  
Amendment Flag true    
Entity Central Index Key 0001752828    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Entity Filer Category Non-accelerated Filer    
Document Period End Date Dec. 31, 2021    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Shell Company false    
Entity Ex Transition Period false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 001-38914    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 83-1702591    
Entity Address, Address Line One 170 Park Ave    
Entity Address, City or Town Florham Park    
Entity Address, State or Province NJ    
Entity Address, Postal Zip Code 07932    
City Area Code 908    
Local Phone Number 768-2170    
Entity Interactive Data Current Yes    
Entity Public Float     $ 128.1
Auditor Firm ID 34    
Auditor Name Deloitte & Touche LLP    
Auditor Location Parsippany, New Jersey    
Documents Incorporated by Reference [Text Block]
DOCUMENTS INCORPORATED BY REFERENCE
None.
   
Amendment Description Celularity Inc. is filing this Amendment No. 1 on Form 10-K/A to amend its original Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Original Form 10-K”), originally filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2022, for the sole purpose of filing revised Exhibits 31.1 and 31.2 in order to include in the certifications set forth in the Exhibits the language of revised paragraph 4(b), which language was inadvertently omitted from the certifications when originally filed. This amendment consists solely of the preceding cover page, this explanatory note, Item 8, Item 9A, the list of exhibits filed with this amendment, the signature page and the revised certifications filed as Exhibits 31.1 and 31.2 to this amendment and the required certifications required by the Sarbanes-Oxley Act in connection with the filing of this amendment. Except as described above, this amendment does not reflect events occurring after the date of the filing of the original Annual Report on Form 10-K or modify or update any of the other disclosures contained therein in any way. Accordingly, this amendment should be read in conjunction with the original Annual Report on Form 10-K and Celularity’s other filings with the SEC. This amendment does not reflect events that may have occurred subsequent to the filing of the Original Form. The filing of this amendment is not an admission that the Original Form 10-K, when filed, included any untrue statement of a material fact or omitted to state a material fact necessary to make a statement not misleading.    
Common Class A [Member]      
Document Information [Line Items]      
Title of 12(b) Security Class A common stock, par value $0.0001 per share    
Trading Symbol CELU    
Security Exchange Name NASDAQ    
Warrant [Member]      
Document Information [Line Items]      
Title of 12(b) Security Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share    
Trading Symbol CELUW    
Security Exchange Name NASDAQ